BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30555759)

  • 1. Outcomes of Early-stage Glottic Carcinoma Treated with Radiation Therapy: A Single Institution Experience.
    AlQahtani M; Maklad AM; Shuja M; AlQahtani KH; AlHussain H; AlDhahri SF; AlAmro A; Aly MM; Tunio MA; Marie A; Alkholaiwi F; Alobida N; Elghazaly AA; Bayoumi Y
    Cureus; 2018 Oct; 10(10):e3444. PubMed ID: 30555759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
    Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
    Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
    Yu E; Shenouda G; Beaudet MP; Black MJ
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
    Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of early-stage glottic carcinoma patients treated with radiotherapy: Egyptian National Cancer Institute (NCI-Egypt) experience.
    Mohamed AE; Hassouna AH; Mosalum HS; Alnagmy AK; Ashour MG
    Rep Pract Oncol Radiother; 2023; 28(4):496-505. PubMed ID: 37795222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of radiation therapy for unresected soft-tissue sarcomas.
    Kepka L; DeLaney TF; Suit HD; Goldberg SI
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):852-9. PubMed ID: 16199316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for local control of early glottic squamous cell carcinomas after definitive radiotherapy.
    Okubo M; Itonaga T; Saito T; Shiraishi S; Mikami R; Sakurada A; Sugahara S; Park J; Tokuuye K; Saito K
    Mol Clin Oncol; 2020 Jun; 12(6):541-550. PubMed ID: 32337036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules.
    Kim TG; Ahn YC; Nam HR; Chung MK; Jeong HS; Son YI; Baek CH
    Clin Exp Otorhinolaryngol; 2012 Jun; 5(2):94-100. PubMed ID: 22737290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.